Delivering hope for parents and critically ill newborns
The University of Utah partners with national reference lab ARUP to precisely diagnose NICU babies who may have a genetic disease
The University of Utah partners with national reference lab ARUP to precisely diagnose NICU babies who may have a genetic disease
Illumina partners with Naked Genetics to engage audiences in the world of next-generation sequencing
A milestone study in Melbourne hopes to pave the way to sequencing every child at birth
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide
At a private summit, Illumina convened a group of health system leaders to discuss strategies for implementing genomics into clinical care
Date | Publication | Title |
---|---|---|
Jul 22, 2024 | India Pharma Outlook | Data Analytics Boosting Next-Gen Sequencing Methodologies |
Jul 11, 2024 | Healthcare Dive | FDA’s lab developed test rule could be first check on agency’s power post-Chevron |
Jul 10, 2024 | Fierce Biotech | Illumina buys Fluent BioSciences to better speak the language of single-cell analysis |
Jul 10, 2024 | BioWorld | Illumina boldly acquires Fluent Bio weeks after Grail divestiture |
Jun 21, 2024 | GEN News | StockWatch: “Final Resolution” Set for Illumina’s GRAIL Saga |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.